3 Growth Companies With High Insider Ownership And Up To 20% Revenue Growth

Simply Wall St.
31 Mar

As the U.S. market navigates the complexities of new tariffs and economic uncertainties, major indices have experienced a downturn, with sectors like automotive facing significant pressure. Amidst this backdrop, investors often seek growth companies with high insider ownership as they can signal strong internal confidence and potential resilience in challenging times.

Top 10 Growth Companies With High Insider Ownership In The United States

Name Insider Ownership Earnings Growth
Super Micro Computer (NasdaqGS:SMCI) 14.2% 29.8%
Hims & Hers Health (NYSE:HIMS) 13.2% 21.8%
Duolingo (NasdaqGS:DUOL) 14.4% 37.1%
Corcept Therapeutics (NasdaqCM:CORT) 11.7% 36.7%
Coastal Financial (NasdaqGS:CCB) 14.5% 46.4%
Astera Labs (NasdaqGS:ALAB) 15.9% 61.3%
BBB Foods (NYSE:TBBB) 16.2% 41.1%
Clene (NasdaqCM:CLNN) 19.5% 63.1%
Upstart Holdings (NasdaqGS:UPST) 12.7% 100.1%
Credit Acceptance (NasdaqGS:CACC) 14.4% 33.6%

Click here to see the full list of 200 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

Viemed Healthcare

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Viemed Healthcare, Inc. operates in the United States offering home medical equipment and post-acute respiratory healthcare services, with a market capitalization of approximately $287.32 million.

Operations: The company's revenue primarily comes from its Sleep and Respiratory Disorders Sector, generating $224.26 million.

Insider Ownership: 13%

Revenue Growth Forecast: 11.5% p.a.

Viemed Healthcare is experiencing robust growth, with earnings projected to increase significantly at 27% annually, outpacing the US market. Revenue for 2024 reached US$224.26 million, up from US$183.01 million the previous year, with net income rising to US$11.27 million. Despite substantial insider selling recently, analysts anticipate a stock price rise of 76.5%. The company forecasts revenue between $254 and $265 million for 2025, highlighting strong growth potential despite recent insider activity concerns.

  • Unlock comprehensive insights into our analysis of Viemed Healthcare stock in this growth report.
  • Our valuation report unveils the possibility Viemed Healthcare's shares may be trading at a premium.
NasdaqCM:VMD Earnings and Revenue Growth as at Mar 2025

Capital Bancorp

Simply Wall St Growth Rating: ★★★★★☆

Overview: Capital Bancorp, Inc. is the bank holding company for Capital Bank, N.A., with a market cap of approximately $467.81 million.

Operations: The company's revenue segments include Opensky at $70.58 million, Commercial Bank at $85.87 million, Windsor Advantage at $4.57 million, Corporate at $0.15 million, and Capital Bank Home Loans (CBHL) at $6.89 million.

Insider Ownership: 31.4%

Revenue Growth Forecast: 20.2% p.a.

Capital Bancorp is poised for growth, with revenue expected to increase by 20.2% annually, surpassing the US market's forecast. The company recently announced a share repurchase program of up to US$15 million, set to expire in February 2026. Despite experiencing insider selling and a decline in net income from US$35.87 million to US$30.97 million last year, analysts predict a 26.4% stock price rise due to its strong value proposition and earnings growth potential at 30% annually.

  • Get an in-depth perspective on Capital Bancorp's performance by reading our analyst estimates report here.
  • Our expertly prepared valuation report Capital Bancorp implies its share price may be lower than expected.
NasdaqGS:CBNK Earnings and Revenue Growth as at Mar 2025

Youdao

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Youdao, Inc. is an internet technology company that offers online services in content, community, communication, and commerce in China with a market cap of approximately $971.69 million.

Operations: The company's revenue is primarily derived from Learning Services (CN¥2.75 billion), followed by Online Marketing Services (CN¥1.97 billion) and Smart Devices (CN¥903.67 million).

Insider Ownership: 20.3%

Revenue Growth Forecast: 10.9% p.a.

Youdao's insider ownership aligns with its growth trajectory, as earnings are expected to rise significantly at 45.7% annually, outpacing the US market. Despite a revenue decline last quarter to CNY 1,339.8 million, net income improved to CNY 83 million. The company completed a share buyback worth $33.8 million but has shown high share price volatility recently. Revenue is forecasted to grow at 10.9% per year, exceeding the broader US market rate of 8.3%.

  • Click to explore a detailed breakdown of our findings in Youdao's earnings growth report.
  • The valuation report we've compiled suggests that Youdao's current price could be inflated.
NYSE:DAO Ownership Breakdown as at Mar 2025

Summing It All Up

  • Access the full spectrum of 200 Fast Growing US Companies With High Insider Ownership by clicking on this link.
  • Contemplating Other Strategies? The end of cancer? These 21 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include NasdaqCM:VMD NasdaqGS:CBNK and NYSE:DAO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10